Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trialDongsheng Wang, Xiaoling Xu, Mingfeng Han et al.|Frontiers of Medicine|2021Cited by 80
Depression and insomnia in COVID-19 survivors: a cross-sectional survey from Chinese rehabilitation centers in Anhui provinceFei Xu, Huanzhong Liu, Xixin Wang et al.|Sleep Medicine|2021Cited by 67